Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. Mari (Roma (RM), Italy), M. Siciliano (Roma (RM), Italy), F. Cefaloni (Roma (RM), Italy), S. Cortese (Roma (RM), Italy), E. Schiavi (Roma (RM), Italy), B. Iovene (Roma (RM), Italy), G. Sgalla (Roma (RM), Italy), G. Corbo (Roma (RM), Italy), F. Varone (Roma (RM), Italy), L. Richeldi (Roma (RM), Italy). Methylprednisolone pulse therapy in Acute Exacerbations of Idiopathic Pulmonary Fibrosis. 810

Member's Comments

No comment yet.

Related content which might interest you: Treatment of Idiopathic Pulmonary Fibrosis Source: Guideline 2015 Year: 2015 Association between Pulmonary Infections and the Prognosis in Patients with Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2021 – Interstitial lung disease around the world Year: 2021 The Effects Of Respiratory Viruses on The Acute Pulmonary Exacerbations In Cystic Fibrosis Patients Source: International Congress 2019 – Insights into paediatric bronchology Year: 2019 Impact of depression on patients with Idiopathic Pulmonary Fibrosis Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases Year: 2017 Characterize Idiopathic Pulmonary Fibrosis using Respiratory Oscillometry Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020 Prevalence and Characteristics of Patients Receiving Antifibrotic Therapy for Idiopathic Pulmonary Fibrosis Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries Year: 2020 Diagnosis and Treatment of Chronic Pulmonary Embolism Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease Year: 2018 Diagnosis and Treatment of Chronic Pulmonary Embolism Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2014 Audit of Duration of Corticosteroid Treatment in Acute Exacerbations of COPD Source: International Congress 2018 – Pharmacological management of COPD Year: 2018 LATE-BREAKING ABSTRACT: Bosentan in Pulmonary Hypertension associated with Fibrotic Idiopathic Interstitial Pneumonia:A Randomized, Double-Blind, Placebo-controlled Study Source: Annual Congress 2013 –Pulmonary circulation: treatment Year: 2013 LSC Abstract – Changes in the respiratory microbiome during acute exacerbations of Idiopathic Pulmonary Fibrosis Source: International Congress 2015 – IPF pathogenesis Year: 2015 Tele-rehabilitation program in Idiopathic Pulmonary Fibrosis Source: International Congress 2019 – M-health/e-health I Year: 2019 Is Pulmonary Rehabilitation A Savior In Idiopathic Pulmonary Fibrosis? Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis Year: 2020 Clinical Features and Prognosis of Acute exacerbation of Connective Tissue Diseases Associated Pulmonary Fibrosis------ Comparision with Idiopathic Pulmonary Fibrosis Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment Year: 2017 Platelet activation indices in patients with Idiopathic Pulmonary Fibrosis Source: International Congress 2014 – ILDs 5 Year: 2014 Idiopathic Pulmonary Haemosiderosis; Factors That Effect Prognosis Source: Virtual Congress 2020 – Tip the hat to paediatric bronchology Year: 2020 The role of infection in acute exacerbation of Idiopathic Pulmonary Fibrosis Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018 Clinical efficacy of Macitentan in patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Interventional Treatment in Chronic Thromboembolic Pulmonary Hypertension with Microvasculopathy Source: Virtual Congress 2020 – Pulmonary embolism and beyond Year: 2020